| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 2e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.24 | 3e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |